Fraud King Drains $178M From California’s Poor

A repeat fraudster drained $178 million from California’s safety-net health program in just 11 months by exploiting a temporary policy loophole, turning taxpayer dollars into personal luxury.

Story Snapshot

Paul Richard Randall orchestrated $270 million in bogus Medi-Cal claims, pocketing over $178 million for fake prescriptions of vitamins and pain creams.
Scheme exploited Medi-Cal’s prior authorization suspension during a 2022 payment system switch, billing inflated rates for cheap generics.
Government seized $126.5 million in assets, including bank funds and luxury items, from Randall and co-schemers.
Randall, already on release for prior crimes, faces up to 30 years; sentencing set for August 3, 2026.
Case highlights vulnerabilities in Medicaid programs, fueling federal anti-fraud task force under President Trump.

Scheme Mechanics and Execution

Paul Richard Randall directed a network that submitted $269,120,829 in fraudulent claims to Medi-Cal from May 2022 to April 2023. Monte Vista Pharmacy, owned by Kyrollos Mekail, billed for 19 drugs like Folite tablets—an over-the-counter vitamin—and custom pain creams never delivered to patients. These non-contracted generics carried high reimbursements because unique dosages evaded price caps. Randall paid kickbacks to marketers for beneficiary data and to nurse practitioner Patricia Anderson for signing pre-filled prescriptions without exams. Proceeds laundered through third parties funded Randall’s 40% cut of pharmacy profits.

Exploitation of Policy Vulnerability

Medi-Cal suspended prior authorization for certain drugs in early 2022 amid transition to a new fee-for-service system. This gap allowed unchecked high-reimbursement claims on medically unnecessary items. Monte Vista Pharmacy billed tens of millions monthly, exploiting Southern California’s program structure. Randall, operating from Orange County, treated the system for low-income families as his piggy bank. Prosecutors note this scale—$178,746,556 paid out—demands accountability to protect vulnerable Californians and taxpayers.

Key Players and Their Roles

Randall, 66, of Orange, masterminded kickbacks and billing. Mekail, 37, of Moreno Valley, ran the pharmacy and pleaded guilty in August 2024 to health care fraud. Anderson, 58, of West Hills, approved fake scripts and pleaded guilty in April 2025. Investigators from HHS-OIG, FBI, and California DOJ unraveled the plot. U.S. Attorney Bill Essayli condemned Randall’s greed. Assistant AG A. Tysen Duva labeled him a repeat fraudster. HHS-OIG’s Scott J. Lampert warned of integrity threats.

Investigations and Guilty Pleas

Randall entered federal custody in June 2025. On April 6, 2026, while on release for another case, he pleaded guilty to wire fraud. Co-schemers followed: Mekail in 2024, Anderson in 2025. Randall agreed to forfeit over $17 million in bank accounts, vehicles, properties, and memorabilia. Total seizures hit $126.5 million, including $111 million in bank funds. Judge Mark C. Scarsi will sentence Randall on August 3, 2026, with a maximum of 30 years. Prosecutors Roger A. Hsieh, Siobhan M. Namazi, and James E. Dochterman handled the case.

Government Response and Seizures

An Orange County man has pleaded guilty to a scheme in which he submitted nearly $270 million in fraudulent claims to Medi-Cal, according to the Department of Justice. https://t.co/PooIV9DUzN pic.twitter.com/vPLsUOHaHb

— KTLA (@KTLA) April 8, 2026

Federal authorities announced the plea alongside two other cases under President Trump’s Task Force to Eliminate Fraud. Essayli stated Randall used the public health program as a personal piggy bank. Duva emphasized aggressive prosecution against such theft. This aligns with conservative priorities: safeguarding taxpayer funds from waste and ensuring programs serve the needy, not criminals. Common sense demands swift justice to deter copycats.

Impacts on Communities and Reforms

Medi-Cal beneficiaries—low-income and vulnerable—suffer strained resources from the $178 million loss. California taxpayers cover the shortfall after $270 million in bogus claims. Short-term recovery includes $126.5 million seized; long-term effects spur scrutiny on prior authorization pauses and reimbursement rules. Broader pharmacy fraud prosecutions signal risks for kickback schemes nationwide. Eroded trust undermines care access, but federal action restores accountability.